Holen Sie sich die Stockscreener-App
5.40
15.62%
-1.00
Schlusskurs vom Vortag:
$6.40
Offen:
$6.51
24-Stunden-Volumen:
5.23M
Relative Volume:
2.15
Marktkapitalisierung:
$15.16M
Einnahmen:
$3.57M
Nettoeinkommen (Verlust:
$-15.74M
KGV:
-0.7772
EPS:
-6.9481
Netto-Cashflow:
$-15.77M
1W Leistung:
+101.49%
1M Leistung:
-18.18%
6M Leistung:
-72.92%
1J Leistung:
-81.05%
1-Tages-Spanne:
$4.85
$6.79
1-Wochen-Bereich:
$2.12
$9.54
52-Wochen-Spanne:
$2.12
$42.00
Icecure Medical Ltd Stock (ICCM) Company Profile
Firmenname
Icecure Medical Ltd
Sektor
Branche
Telefon
-
Adresse
-
Compare ICCM vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ICCM
Icecure Medical Ltd
|
5.40 | 15.16M | 3.57M | -15.74M | -15.77M | -6.9481 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Icecure Medical Ltd Aktie (ICCM) Neueste Nachrichten
IceCure Medical (ICCM) prices $5.5M private placement with warrant package - Stock Titan
IceCure Medical gains after ProSense update, $5.5M placement - TechStock²
IceCure announces pricing of private placement - Medical Buyer
Tumour freezing specialist IceCure Medical skyrockets from latest successes - Mugglehead Investment Magazine
Icecure Medical Ltd (ICCM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Icecure Medical Ltd (ICCM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Icecure Medical Ltd (ICCM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Icecure Medical Ltd (ICCM) Valuation: PE, PB & Fair Value Analysis - TradingKey
Icecure Medical Ltd (ICCM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Icecure Medical Ltd (ICCM) Institutional Confidence - TradingKey
Icecure Medical Ltd (ICCM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Icecure Medical Ltd (ICCM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
ICCM Stock Price, Quote & Chart - ChartMill
BIRD, NBIS, ICCM, HOOD, META: 5 Trending Stocks TodayRobinhood Markets (NASDAQ:HOOD) - Benzinga
IceCure Medical Ltd announced that it has received $5.499819 million in funding - marketscreener.com
IceCure Medical (ICCM) Sees Significant Growth in ProSense Insta - GuruFocus
IceCure Announces Pricing of $5.5 Million Private Placement Priced At a Premium to the Market Price with a Single Healthcare Focused Institutional Investor - PR Newswire
IceCure Medical (ICCM) Sees 70% Surge in Cryoablation Install Ba - GuruFocus
IceCure Stock Surges After 70% ProSense Install Increase - Benzinga
ICCM Stock On Track For Best Day In Nearly 5 Years — What’s Driving The 200% Rally? - TradingView
Stock Gains on News of 70% Surge in U.S. ProSense Install Base Fuels IceCure's (NASDAQ: ICCM) Breast Cancer Treatment Momentum - Investorideas.com
IceCure Medical jumps on U.S. ProSense install base growth after FDA clearance - TechStock²
IceCure Medical surges after update on U.S. ProSense adoption following FDA breast-cancer authorization - Quiver Quantitative
2 Stocks To Watch Today: ICCM, OCUL - RTTNews
ICCM Stock Explodes As New Cancer Data Fuels Trading Frenzy - StocksToTrade
Why is IceCure Medical stock surging today? By Investing.com - Investing.com South Africa
ICCM Stock Draws Traders As ProSense Data Impresses - timothysykes.com
Why is IceCure Medical stock surging today? - Investing.com
IceCure Reports 70% Growth in Active U.S. Commercial Install Base for Breast Cancer Cryoablation Following FDA Clearance - StreetInsider
IceCure Reports 70% Growth in Active U.S. Commercial Install Base for Breast Cancer Cryoablation Following FDA Clearance - Benzinga
IceCure Medical Ltd announced that it expects to receive $5.499819 million in funding - marketscreener.com
IceCure Medical (ICCM) Falls Over 11%: Key Support Levels Tested After Sharp DeclineCall Resistance - newsline.com
Icecure Medical Analyst Ratings and Price Targets | NASDAQ:ICCM - Benzinga
IceCure Medical to boost share price with 1-for-30 reverse split to regain NASDAQ compliance - MSN
IceCure Medical announces reverse share split - Medical Buyer
IceCure Medical (ICCM) Announces 1-for-30 Reverse Stock Split to Meet Nasdaq Requirements - GuruFocus
IceCure Medical: Split Part of Co's Proactive Efforts to Regain Compliance With Nasdaq $1 Minimum Bid Price Requirement and Support Co's Broader Cap Markets Strategy >ICCM - Moomoo
IceCure Medical (ICCM) Announces 1-for-30 Reverse Stock Split to Maintain Nasdaq Listing - GuruFocus
IceCure Medical Announces 1-for-30 Reverse Share Split to Maintain Nasdaq Listing - geneonline.com
IceCure Stock Drops Before The Bell As Nasdaq’s $1 Clock Ticks - Bez Kabli
IceCure Medical (NASDAQ: ICCM) implements 1-for-30 reverse share split for Nasdaq - Stock Titan
IceCure Medical Announces 1-for-30 Reverse Share Split to Support Nasdaq Compliance - PR Newswire
IceCure consolidates shares 30-to-1 in bid to keep Nasdaq listing - Stock Titan
Why Has IceCure Medical's Stock Price Collapsed - Kavout
Number of shareholders of IceCure Medical Ltd. – BOATS:ICCM - TradingView
IceCure Medical (ICCM) Retreats Toward Support After 4% DeclineFair Value Gap - newsline.com
IceCure Medical (ICCM) Edges Higher as Stock Tests Key Resistance Near $0.24Advance Decline Volume - The Legal Advocate
Icecure Medical Earnings Call Highlights Growth Momentum - The Globe and Mail
Icecure Medical Ltd (ICCM) Q1 2026 Earnings Call Highlights: Robust Revenue Growth and ... By GuruFocus - Investing.com Canada
Icecure Medical Ltd (ICCM) Q1 2026 Earnings Call Highlights: Rob - GuruFocus
IceCure Medical presents positive ProSense cryoablation data - grafa.com
Finanzdaten der Icecure Medical Ltd-Aktie (ICCM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):